Novel Formulation of Fusidic Acid Incorporated into a Myrrh-Oil-Based Nanoemulgel for the Enhancement of Skin Bacterial Infection Treatment.

antibacterial fusidic acid myrrh essential oil nanoemulgel optimization

Journal

Gels (Basel, Switzerland)
ISSN: 2310-2861
Titre abrégé: Gels
Pays: Switzerland
ID NLM: 101696925

Informations de publication

Date de publication:
15 Apr 2022
Historique:
received: 10 03 2022
revised: 07 04 2022
accepted: 10 04 2022
entrez: 21 4 2022
pubmed: 22 4 2022
medline: 22 4 2022
Statut: epublish

Résumé

Fusidic acid (FA) is renowned as an effective bacteriostatic agent obtained from the fungus Fusidium coccineum, used for treating various eye and skin disorders. The objective of the present study was to develop, characterize, and evaluate the antibacterial activity of a novel FA nanoemulgel for topical skin application. Primarily, various fusidic acid nanoemulsion formulations were fabricated using different concentrations of myrrh essential oil, Tween 80 as a surfactant, and Transcutol® P as a co-surfactant. A Box−Behnken design was employed to select the optimized FA nanoemulsion formulation, based on the evaluated particle size and % of in vitro release as dependent variables. The optimized formula was incorporated within a hydrogel to obtain an FA nanoemulgel (FA-NEG) preparation. The formulated FA-NEG was evaluated for its visual appearance, pH, viscosity, and spreadability, compared to its corresponding prepared fusidic acid gel. In vitro release, kinetic study, and ex vivo drug permeation were implemented, followed by formulation stability testing. The FA-NEG exhibited a smooth and homogeneous appearance, pH value (6.61), viscosity (25,265 cP), and spreadability (33.6 mm), which were all good characteristics for appropriate topical application. A total of 59.3% of FA was released from the FA-NEG after 3 h. The ex vivo skin permeability of the FA-NEG was significantly enhanced by 3.10 ± 0.13-fold, showing SSTF of 111.2 ± 4.5 µg/cm2·h when compared to other formulations under investigation (p < 0.05). No irritation was observed upon applying the FA-NEG to animal skin. Eventually, it was revealed that the FA-NEG displayed improved antibacterial activity against a wide variety of bacteria when compared to its corresponding FA gel and marketed cream, indicating the prospective antibacterial effect of myrrh essential oil. In conclusion, the recommended formulation offers a promising antibacterial approach for skin infections.

Identifiants

pubmed: 35448146
pii: gels8040245
doi: 10.3390/gels8040245
pmc: PMC9027726
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Deanship of Scientific Research, King Faisal University, Ra'ed track
ID : grant number 207020.

Références

Artif Cells Nanomed Biotechnol. 2015;43(5):334-44
pubmed: 24641773
Zhongguo Zhong Yao Za Zhi. 2017 Feb;42(4):680-685
pubmed: 28959837
Int J Pharm. 2012 Jan 17;422(1-2):245-53
pubmed: 22100514
Drug Dev Ind Pharm. 2014 Jan;40(1):66-73
pubmed: 23298324
Biomed Res Int. 2021 Oct 11;2021:5247816
pubmed: 34671674
Sci Rep. 2020 Feb 27;10(1):3595
pubmed: 32108167
Hum Vaccin Immunother. 2015;11(7):1853-64
pubmed: 26090563
Pharmaceutics. 2017 Sep 06;9(3):
pubmed: 28878145
Gels. 2021 Dec 25;8(1):
pubmed: 35049551
Int J Pharm Investig. 2014 Apr;4(2):65-76
pubmed: 25006551
J Control Release. 2009 Jun 5;136(2):88-98
pubmed: 19250955
3 Biotech. 2015 Apr;5(2):123-127
pubmed: 28324579
Food Chem. 2015 Mar 15;171:117-22
pubmed: 25308650
Eur J Pharm Biopharm. 2018 Jul;128:170-178
pubmed: 29680482
J Nanobiotechnology. 2018 Sep 19;16(1):71
pubmed: 30231877
Acta Pol Pharm. 2010 May-Jun;67(3):217-23
pubmed: 20524422
Molecules. 2021 Jun 07;26(11):
pubmed: 34200144
Int J Pharm. 2010 Apr 15;389(1-2):186-94
pubmed: 20038446
Cells. 2021 Sep 13;10(9):
pubmed: 34572054
Polymers (Basel). 2021 Feb 14;13(4):
pubmed: 33672981
Adv Drug Deliv Rev. 2018 Jan 1;123:65-74
pubmed: 28964882
Molecules. 2020 May 27;25(11):
pubmed: 32471063
Lett Appl Microbiol. 2012 Apr;54(4):352-8
pubmed: 22288378
Pharmaceutics. 2020 Dec 17;12(12):
pubmed: 33348692
J Oleo Sci. 2011;60(4):155-8
pubmed: 21427510
J Pharm Sci. 2017 Jul;106(7):1736-1751
pubmed: 28412398
Molecules. 2019 Jul 29;24(15):
pubmed: 31362362
Eur J Pharm Sci. 2020 May 30;148:105323
pubmed: 32259677
Pharmaceutics. 2020 Feb 25;12(3):
pubmed: 32106544
Molecules. 2021 Jun 24;26(13):
pubmed: 34202733
Biomed Res Int. 2019 Jan 17;2019:8928306
pubmed: 30792999
AMB Express. 2020 Jan 28;10(1):21
pubmed: 31993779
Gels. 2021 Nov 18;7(4):
pubmed: 34842709
Pharmaceutics. 2019 Nov 13;11(11):
pubmed: 31766305
Int J Nanomedicine. 2019 Dec 02;14:9411-9421
pubmed: 31819440
Nanomaterials (Basel). 2020 Apr 28;10(5):
pubmed: 32353979
AAPS PharmSciTech. 2018 Nov;19(8):3512-3533
pubmed: 30421383
J Food Sci. 2016 Mar;81(3):N745-53
pubmed: 26807662
Drug Deliv. 2015;22(7):911-7
pubmed: 24401095
J Drug Target. 2015 Dec;23(10):943-52
pubmed: 26004269
Biomater Res. 2019 Nov 21;23:20
pubmed: 31832232
Pharmaceutics. 2020 Feb 13;12(2):
pubmed: 32069850
Int J Biol Macromol. 2018 Aug;115:1012-1025
pubmed: 29680503
Colloids Surf B Biointerfaces. 2021 Sep;205:111868
pubmed: 34034223
Polymers (Basel). 2021 Mar 04;13(5):
pubmed: 33806659
Int J Pharm. 2019 Jan 30;555:314-321
pubmed: 30439490

Auteurs

Mervt M Almostafa (MM)

Department of Chemistry, College of Science, King Faisal University, Alhofuf 31982, Saudi Arabia.

Heba S Elsewedy (HS)

Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Alhofuf 36362, Saudi Arabia.

Tamer M Shehata (TM)

Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Alhofuf 36362, Saudi Arabia.
Department of Pharmaceutics, College of Pharmacy, Zagazig University, Zagazig 44519, Egypt.

Wafaa E Soliman (WE)

Department of Biomedical Sciences, College of Clinical Pharmacy, King Faisal University, Alhofuf 36362, Saudi Arabia.
Department of Microbiology and Immunology, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, Mansoura 11152, Egypt.

Classifications MeSH